AITC inhibits tumor growth by both antiangiogenic and proapoptotic mechanisms.
The authors investigate the antiangiogenic and proapoptotic effects of mustard essential oil containing allyl isothiocyanate (AITC) and explore its mechanism of action on Ehrlich ascites tumor (EAT) cells. Swiss albino mice transplanted with EAT cells were used to study the effect of AITC. AITC was effective at a concentration of 10 µm as demonstrated by the inhibition of proliferation of EAT cells when compared with the normal HEK293 cells. It significantly reduced ascites secretion and tumor cell proliferation by about 80% and inhibited vascular endothelial growth factor expression in tumor-bearing mice in vivo. It also reduced vessel sprouting and exhibited potent antiangiogenic activity in the chorioallantoic membrane and cornea of the rat. AITC arrested the growth of EAT cells by inducing apoptosis and effectively arrested cell cycle progression at the G1 phase. The results clearly suggest that
Introduction
Cruciferous vegetables contain relatively large amounts of isothiocyanate (ITC) either as such or as the precursor gluocosinolates from which ITCs are liberated by the action of the enzyme myrosinase. [1] [2] [3] ITCs are a family of small organic compounds that occur in a wide variety of plants, many of which are consumed by humans on a regular basis. 4, 5 For example, mustard, garden cress, water cress, and broccoli are rich sources of allyl-ITC (AITC), 6 benzyl-ITC (BITC), 7 phenethyl-ITC (PEITC), 8 and sulforaphane (SF), 9, 10 respectively. Mustard (Brassica juncea) has always held an important place in medicine. The ancient Greeks believed it had been created by Asclepius, the god of healing, as a gift to mankind. Over the years, mustard has been prescribed for scorpion stings, snake bites, epilepsy, toothache, stiff neck, rheumatism, colic, and respiratory troubles. AITC has been shown to induce strongly glutathione-S-transferase and quinine reductase activities. 11, 12 Naturally occurring AITC has also been implicated in the inhibition of B16F-10 melanoma cell-induced metastasis and tumor colony formation by 93% after 21 days of tumor induction in C57BL/6 mice 13 ; there was also a corresponding increase in the life span of AITC-treated animals. Epidemiological and experimental studies suggested that diets rich in cruciferous vegetables are associated with reduction in the relative risks of colorectal carcinoma, lung cancer, and possibly prostate cancer. [14] [15] [16] [17] [18] These results suggest that naturally occurring AITCs are a class of promising chemopreventive agents that could play important roles in modulating the activation and detoxification of carcinogenesis.
The excessive formation of new blood vessels (angiogenesis) is a part of the pathological regulatory mechanisms in various diseases, including atherosclerosis, rheumatoid arthritis, diabetic retinopathy, and solid tumor. [19] [20] [21] Furthermore, angiogenesis is a property of most solid tumors and is necessary for their continued growth. 22 There are many inducers of blood vessel formation, which include vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and angiopoietins. Inhibitors of angiogenesis include heparin, endostatin, and angiostatin. Thus, the balance of these inducers and inhibitors would result in endothelial cell quiescence or angiogenesis. 23 Because the expression of VEGF has been implicated in tumor angiogenesis, pharmacological intervention that affects the VEGF expression may influence disease progression in and prognosis for cancer patients. 24 Homeostasis between cell death and cell proliferation is required to maintain normal state. Apoptosis, through which the majority of programmed cell deaths occur, plays an important role in the regulation of tissue development and homeostasis in eukaryotes. 25 Disruption of this balance leads to many diseases, including cancer. Its morphological characteristics include plasma membrane blebbing, cell shrinkage, nuclear condensation, chromosomal DNA fragmentation, and formation of apoptotic bodies. 26 In this context, it is noteworthy that antiangiogenic and apoptosis-inducing ability seem to have become primary factors in considering the efficacy of chemopreventive agents. Encouraged by this information, an attempt was made to decipher the antiangiogenic and proapoptotic effects of essential oil rich in AITC extracted from mustard seeds on Ehrlich ascites tumor (EAT) cells. We report here that the essential oil of mustard rich in AITC effectively inhibits EAT cell proliferation and induces apoptosis via caspase-3, which can be useful for therapeutic strategies in the future.
Materials and Methods

Chemicals and Reagents
Dulbecco's minimum essential medium (DMEM), fetal bovine serum (FBS), penicillin, and streptomycin were purchased from GIBCO laboratories, Grand Island, NY. Hydron and AITC were from Sigma Co, USA. Anticaspase-3 activated DNase, anti-Bax (bcl-2 associated protein X), and anti-Bcl-2 antibodies were purchased from Santacruz Biotechnology, CA. All other reagents were of highest analytical grade.
Extraction of the Essential Oil AITC From Mustard Seeds
The essential oil AITC was extracted from mustard seeds using the following procedure. One kilogram of mustard seeds was cleaned with distilled water, dried below 60°C, then ground before passing through a 0.5 mm screen, and then soaked in 5 L of distilled water (pH 7). The mixture was allowed to stand for 5 hours at 50°C for hydrolyzation of glucosinolates and then hydrodistilled using a stationary distillator at 100°C and airflow of 5 L/ min. The distillate containing water and the essential oil was collected in several separatory funnels from a multiopening condenser and allowed to stand for 2 hours to separate the oil from the water phase. The water phase was discarded, and the collected essential oil was further distilled to remove impurities and then rehydrated by passing it through a 5-cm column of anhydride sodium sulfate. 27
Analysis of Essential Oil AITC by Gas Chromatography
We took 0.5 mL of mustard seed extract in a thickwalled screw-cap test tube. Distilled water was added to the extract at the rate of 10 times the seed weight. The cap was closed, and the test tube was kept standing for half an hour. Then, 100 µL of 100 mM AITC (Sigma-Aldrich) in absolute ethanol was added as an internal standard to 10 mL of deionized water. The homogenate was extracted twice with 10 mL of dichloromethane using Remi Microprocessor centrifuge at 1000 rpm. The pooled dichloromethane extracts were concentrated to 1 mL by air-drying before injecting onto a gas chromatograph (Netel-1900). We used a 25 m × 0.52 µm column, with a temperature program starting at 70°C and rising linearly to 120°C over 17 minutes. Detection was done using a flame ionization detector. Response factors were determined by adding 100 µL of 100 mM AITC in absolute ethanol to 10 mL of deionized water and subjecting this standard to the same extraction procedure and chromatography procedure used for unknown samples. The percentage purity of the AITC in the extract was 96.48%. 27 (This part of the work was done at Mustard Research and Promotion Consortium, Janakpuri, New Delhi, India).
Cell Culture and Assessment of Cell Growth and Viability
The mouse mammary carcinoma cell line, EAT, was grown in DMEM supplemented with 10% heat-inactivated FBS and 1% penicillin/streptomycin in a humidified incubator (5% CO 2 in air at 37°C). Cells were seeded in 6 well plates prior to AITC addition. The EAT cells were incubated with different doses (1 µM, 5 µM, 10 µM, and 15 µM of solution in ethanol) of AITC for 24, 48, and 72 hours. Cultures were harvested and monitored for cell number by counting cell suspensions with a hemocytometer. Cell growth and viability were checked before and after treatment with AITC using trypan blue exclusion and examined using phase contrast microscopy.
[ 3 H] Thymidine Uptake Assay
To verify the in vitro effect of AITC on the proliferation of EAT and HEK293 (normal) cells, the cells were cultured in vitro in DMEM medium supplemented with 10 % FBS and 1 mg/mL penicillin/streptomycin, and were grown in 5% CO 2 atmosphere at 37°C for 2 days. 3[H] thymidine (0.03 MBq/mL of medium) was added prior to the addition of AITC (1 µM, 5 µM, 10 µM, and 15 µM of solution in ethanol). After 2 days, the cells were processed for liquid scintillation counting. 28
Animals and Cell Model
Swiss albino mice, and New Zealand rabbits and rats were obtained from the central animal facility, Department of Studies in Zoology, University of Mysore, Mysore, India. All the experiments were approved by the institutional animal care and use committee, University of Mysore, Mysore, India. Fertilized eggs were purchased from the government poultry farm, Bangalore, India. EAT was obtained from the American type culture collection (Rockville, IN).
Culture of EAT Cells in Vivo and AITC Treatment
EAT cells (5 × 10 6 ) were injected intraperitoneally (i.p.) into 8-week-old Swiss Albino mice. Weights of the animals were monitored for 12 days to ensure tumor growth. AITC was diluted in ethanol to obtain the desired different working concentrations (5 µM,10 µM, and 15 µM) and was injected intraperitoneally from the sixth day to monitor the in vivo effect of the essential oil AITC on EAT cell growth and proliferation in vivo. The animals were sacrificed on the 12th day. They were then dissected to observe the effect of the AITC on peritoneal angiogenesis.
Cell Number and Ascites Volume
Cells along with the ascites fluid were collected from both control and treated animals. The harvested cells were resuspended in phosphate buffered saline (PBS) and counted using a hemocytometer and the trypan blue dye exclusion method. The volume of ascites obtained from control and treated animals was noted.
Production of VEGF 165 and Raising of Polyclonal Antibody for VEGF-ELISA
Bacterial expression of VEGF was carried out according to the method described by Siemeister et al 29 The bacterially expressed recombinant VEGF 165 was used as a standard in ELISA. The protein was gel eluted from SDS-PAGE and used as an antigen to raise polyclonal antibodies in the New Zealand white male rabbit. The antibodies collected from the serum of the immunized animal were purified by ammonium sulfate precipitation and immunoaffinity purification.
VEGF-ELISA
The level of VEGF secreted by EAT cells into the peritoneal ascites was measured by ELISA as described in detail by Belakavadi and Salimath. 30 In brief, 100 µL of ascites from control or AITC-treated mice was coated using a coating buffer at 4°C overnight. Subsequently, wells were washed and blocked with blocking buffer followed by incubation with anti-VEGF 165 antibodies. Bacterially expressed recombinant VEGF 165 was used to set up the standard curve. After incubation for 2 hours, the wells were washed with PBST before being treated with 100 µL of secondary antibodies tagged to alkaline phosphatase. Incubation was continued for 2 hours at room temperature, and the plate was washed prior to the addition of 100 µL of substrate (pNPP). The optical density at 405 nm was measured in a MediSpec ELISA reader.
Chorioallantoic Membrane (CAM) Assay
CAM assay was carried out according to the procedure described by Gururaj et al. 31 In brief, fertilized eggs were incubated for 11 days at 37°C in a humidified atmosphere. On the 11th day, a window was made under aseptic conditions on the eggshell. PBS, VEGF, or AITC (10 µM) was air dried on a glass cover slip. The cover slip was inverted over the CAM and the window resealed. The eggs were incubated for an additional 2 days. On the 13th day, the window was opened and inspected for change in microvessel density in the area under the cover slip and photographed.
Rat Corneal Angiogenesis Assay
This assay was performed as previously described. 32, 33 Briefly, sterile casting solution was prepared by dissolving poly-2-hydroxylethylemethacrylate (Hydron, Sigma Co., USA) powder in absolute alcohol (12% w/v) in a rotator at 37°C overnight. Then, 1 µg/µL of VEGF was mixed with 2 µL of the above solution. This mixture was pipetted on to the surface of sterile Teflon rods to make a pellet 2 mm in diameter; 1 µL of AITC (10 µM) was pipetted on to the pellet and allowed to dry. After drying at room temperature in a sterile environment for 1 to 2 hours, the pellets were stored at 4°C. For pellet implantation, rats were anesthetized with the combination of ketamine hydrochloride (20 mg/kg) and xylazine hydrochloride (6 mg/kg). The eye was gently proptosed and secured by clamping the upper eyelid with a nontraumatic hemostat under a surgical microscope. A 1.5 mm incision was made at the center of the cornea but not through it. An approximately 1.5 mm wide, curved microdissector was then inserted under the lip of the incision and gently blunt dissected through the stroma toward the limbus of the eye. Once the corneal pocket was made, the pellet (hydron polymer with saline, hydron polymer with VEGF, and hydron polymer with VEGF + AITC) was rehydrated with saline and positioned down to the base of the pocket. Corneas were examined daily with the aid of a surgical microscope to monitor angiogenic responses to AITC. An antibiotic ointment (terramycin) was applied to the eyes once a day. On the seventh day, the corneas were examined under a surgical microscope (Leica M651) and photographed with the digital camera. The number of blood vessels and length of the vessels was quantified using the software Image Tools v. 2.0. The area of corneal neovascularization was determined with the reticule by measuring the vessel length (L) from the limbus and the number of clock hours (C) of the limbus involved. The contiguous circumferential zone of neovascularization was measured as clock hours with a 360° reticule (where 30° of arc equaled 1 clock hour). Only the uniform contiguous band of neovascularization adjacent to the pellet was measured. The area of the circular band segment was calculated using the formula C/12 × 3.1416(r 2 − [r − L] 2 ), where C = clock hour (30°) and r = 2.5 mm, the measured radius of the rat cornea.
DNA Fragmentation Assay
EAT cells were treated with or without AITC (10 µM) for different time intervals of 0, 2, 4, 8, and16 hours in vitro. The cells were lysed in a buffer containing 50 mM Tris-HCl, pH 8.0, and 0.5% SDS, incubated for 30 minutes at 37°C. The cell lysate was subjected to 8M potassium acetate precipitation and left for 1 hour at 4°C. The suspension was centrifuged at 7000 rpm for 1 hour at 4°C to remove cell debris. The supernatant was subjected to extraction using distilled phenol, chloroform, and isoamyl alcohol in the ratio 25:24:1 by centrifugation at 3000 rpm for 30 minutes. The supernatant containing nucleic acids was incubated with RNase (20 µg/mL) for 10 minutes at 37°C, and the DNA was precipitated with ice-cold ethanol. The precipitated DNA was dissolved in a minimum quantity of TE buffer and quantitated spectrophotometrically. An equal concentration of DNA (10 µg) was resolved on 1% agarose gel, viewed under UV light, and documented using Uvp-BioDoc-ItTM system.
Giemsa, Ethidium Bromide/ Acridine Orange Staining
Nuclear staining was performed according to the method described by Srinivas et al. 34 Briefly, EAT cells, either treated or untreated with AITC solution (10 µM) for 16 hours in vitro, were smeared on a clean glass slide and fixed with methanol and acetic acid (3:1) and air-dried. The cells were hydrated with PBS and stained with a mixture (1:1) of acridine orange/ethidium bromide (4 µg/mL) and/or Giemsa solutions. They were immediately washed with PBS and viewed under a Leitz-Diaplan fluorescent microscope for acridine orange/ethidium bromide staining.
Western Blot Analysis of Caspase-Activated DNase (CAD), Bax, and Bcl-2
EAT cells were treated with AITC (10 µM) for different time intervals of 0, 1, 2, 4, and 8 hours in vitro. Cells were homogenized in a lysis buffer (50 mM Tris-HCl, pH 8.0, 5 mM EDTA, 150 mM NaCl, 0.5% NP-40, 0.5 mM phenylmethylsulfonyl fluoride, 10 µg/mL leupeptin, and 0.5 mM dithiothritol) for 30 minutes on ice. The cell debris was pelleted by centrifugation at 10 000g and 4°C for 30 minutes. For the preparation of nuclear extract, the cells were extracted in a buffer containing 50 mM Tris-HCl, pH 7.5, 10 mM MgCl 2, 1 mM CaCl 2 , 1 mM EDTA, 0.25 M sucrose, 1 mM PMSF, 2 mg/mL leupeptin, and 10 mg/mL aprotenin. About 60 µg of nuclear and/or cytosolic proteins as estimated by Lowry's method were separated on 12.5% SDS-PAGE and transferred to nitrocellulose membranes. After blocking with 5% nonfat skimmed milk powder in Tris-buffered saline, the membranes were incubated with antibodies against CAD (DNA fragmentation factor-40, DFF-40), Bax, and Bcl-2. The blots were washed thrice with TBST on a shaker and incubated with secondary antibody tagged to alkaline phosphatase for 2 hours. After washing with TBST for 10 minutes, the CAD, Bax, and Bcl-2 proteins were detected using the chromogenic substrate BCIP/NBT.
Detection of Apoptosis by Flow Cytometry
For the determination of cell cycle phase distribution, EAT cells, either untreated or treated with AITC (10 µM) for different time intervals, were collected, centrifuged, and washed twice with PBS at room temperature. The cell pellets were resuspended in ice-cold 70% ethanol for overnight fixation at 4°C. The suspension was centrifuged, and the cell pellet was resuspended in 0.8 mL PBS containing 1 µL of RNase (10 mg/mL) and 20 µL of propidium iodide (PI; 1 mg/mL) and incubated for 30 minutes at 37°C before analysis by flow cytometry. A total of 10 000 events were acquired, and analysis of flow cytometric data was performed using ModFit software. A histogram of DNA content (x-axis, PI fluorescence) versus counts (y-axis) has been displayed. Apoptosis was quantitatively measured as the percentage of cells in the sub-G0 region.
Statistical Analysis
Unless stated otherwise, all experiments were performed in triplicate. Wherever appropriate, the data were expressed as the mean ± standard error of the mean (SEM), and means were compared using a 1-way analysis of variance (ANOVA). The statistical significance of differences between control and AITC-treated tumor cells was determined using Tukey's post hoc test. Statistical significance was defined as P < .05 for all the tests. All the analyses were performed using GLM univariate procedure, using SPSS for Windows (version 10.0).
Results
Effect of AITC on Cell Growth and Viability of EAT Cells in Vitro
To investigate the potential effects of AITC on the proliferation and survival of EAT cells, the cells were exposed to different doses (1 µM, 5 µM, 10 µM, and 15 µM) of AITC for 24, 48, and 72 hours. Figures 1A and 1B show that AITC induces cell death in a dose-and time-dependent manner, as determined using trypan blue exclusion. Furthermore, exposure to AITC was associated with cell shrinkage as detected in phase-contrast micrographs (Figure 2 ).
Antiproliferative Effect of AITC
To gain insight into the antiproliferative effect of AITC on EAT cells, we performed a [ 3 H] thymidine incorporation assay. Significant dose-dependent growth inhibition of EAT cells was observed on treatment with AITC. The results shown in Figure 3 clearly indicate that AITC inhibits proliferation in a dose-dependent manner when compared with 100% proliferation of EAT cells in vitro in the absence of AITC. An F test showed a significant difference between different treatments (F = 910.158; P < .001), and growth inhibition of EAT cells was maximum for 15 µM of AITC in comparison with the controls. However, no effect was seen on the proliferation of the normal HEK 293 cells, except at 15 µM. This inhibition of proliferation of normal HEK 293 cells at 15 µM may be attributed to the toxicity of the compound. 
AITC Inhibits Proliferation and Decreases the Ascites Secretion From EAT Cells in Vivo
In an attempt to understand the in vivo effect of AITC on proliferation of EAT cells, Swiss Albino mice were treated with various concentrations of AITC (5 µM, 10 µM, and 15 µM). It was found that AITC showed significant antiproliferative effect toward EAT cells in vivo as monitored by the body weight and is shown in Figure 4A . In contrast, the weights of untreated EAT-bearing mice steadily increased, and they died in a normal growth period of 13 to 14 days. The total cell numbers from each group of mice, either treated or untreated with AITC, as counted by the trypan blue dye exclusion method are shown in NOTE: Ehrlich ascites tumor (EAT) cells (5 × 10 6 cells/mouse, intraperitoneal [i.p.]) were injected into mice, and weights of the mice were recorded. After the sixth day of the tumor inoculation, AITC (5 µM, 10 µM, and 15 µM) or phosphate buffered saline (PBS) was injected i.p. every day. A minimum of 3 mice were used for the experiment, and results obtained are an average of 3 individual experiments. EAT-bearing mice treated with PBS or AITC were sacrificed on the 12th day. EAT cells along with ascites fluid were harvested. Number of cells per mouse was determined by counting the cells in a hemocytometer, and ascites volume was recorded. The data represent the mean ± SEM of 3 independent experiments. Effect of AITC is statistically significant in comparison with controls (P < .001). Figure 4B , which confirmed the cell growth inhibition by AITC. Because EAT cells grow as an ascites tumor, we measured the volume of ascites secreted from the control group and the group that received AITC treatment. About 85% of ascites secretion was inhibited with AITC treatment as shown in Figure 4C . Statistical analysis by the F test revealed that body weight changed significantly with the concentration (F = 811.492; P < .001). Body weights between days also showed significant difference (F = 141.709; P < .001), where maximum body weight was observed during days 8, 7, and 6, and least body weight was observed on day 2, which was further confirmed by Tukey's post hoc test. The interaction between concentration and days was found to be highly significant (F = 41.434; P < .001): Up to the fifth day, we found more or less increases in body weight, but after the fifth day, there was a linear increase only for control mice, whereas for other concentrations of AITC, a decrease in body weight was found. A significant difference was observed between number of cells and different treatments (F = 6005.79; P < .001). Similarly, a significant difference was also observed between ascites volume and different treatments (F = 954.455; P < .001), where the number of cells and volume of ascites were highest in controls followed by those in 5 µM, 10 µM, and 15 µM concentrations of AITC. However, no such significant difference was observed between treatments with 10 µM and 15 µM of AITC.
Suppression of Peritoneal Angiogenesis by AITC
To evaluate the effect of AITC on peritoneal angiogenesis, the animals were dissected on the 13th day to observe the effect of AITC on the extent of angiogenesis. Figure 5 clearly indicates the extent of angiogenesis in the peritoneum of untreated EAT-bearing mice. Mice treated with different concentrations (5 µM, 10 µM, and 15 µM) of AITC showed significant inhibition of in vivo angiogenesis in the peritoneum of tumor-bearing mice.
AITC Inhibits VEGF Production by EAT Cells
Increase in peritoneal angiogenesis in tumor-bearing mice is attributed to the presence of VEGF in the ascites secreted by EAT cells. Quantification of VEGF in the ascites of either treated or untreated mice indicated that AITC interferes with the production of VEGF in vivo in EAT-bearing mice. In Figure 6 , we compare the amount of VEGF for untreated and AITC-treated EAT cells. The amount of VEGF production is increased in the ascites of untreated cells when compared with that observed in the ascites of EAT-bearing mice treated with AITC (5 µM, 10 µM, and 15 µM). When compared with controls, approximately 40% inhibition is seen in the amount of protein expressed in AITC-treated cells. The F test showed a significant difference between the amounts of VEGF in different treatments (F = 9193.409; P < .001), and the amount of VEGF was highest in control, tumor-bearing mouse ascites. However, no significant difference was observed between treatments of 10 µM and 15 µM of AITC as revealed by Tukey's HSD (honestly significant differences) test.
Angioinhibitory Effect of AITC
Chorioallantoic membrane (CAM) assay and rat cornea assay are the standard angiogenesis assays used for validation of angioinhibitory activity of any compound. In vivo angioinhibitory effect of AITC was clearly evident from results obtained in the CAM assay. Results as shown in Figure 7A , exhibit reduction of angiogenesis in the CAM at the site of application of AITC when compared with the extensive angiogenesis seen in the normal CAM. The data shown represent the results using a minimum of 5 eggs in each group. The angioinhibitory effect of AITC 
AITC Induces Degradation of DNA in EAT Cells
The degradation of DNA into multiple internucleosomal fragments is a distinct biochemical hallmark for apoptosis. Results shown in Figure 8 clearly indicate that AITC activated fragmentation of chromosomal DNA in EAT cells, whereas cells that were not treated with AITC did not show any change in chromosomal integrity. The fragmentation of chromosomal DNA of EAT cells by AITC was verified in a time-dependent manner.
AITC Induces Nuclear Condensation of EAT Cells
An attempt was made to verify that the inhibition of proliferation of EAT cells was caused by the apoptosis-inducing NOTE: Phosphate buffered saline, vascular endothelial growth factor (VEGF), or AITC (10 µM) were applied on the CAM of the 11-day-old chick embryo, and the window was sealed. The window was reopened on the 13th day, and the applied area was inspected for changes in vessel density. Hydron polymer, VEGF, or VEGF with AITC were implanted into the cornea of the rat. On the seventh day, the cornea was inspected for the inhibition of VEGF-induced corneal angiogenesis by incorporation of AITC in the hydron polymer. Changes in the number of blood vessels in the rat cornea on the seventh day, changes of the length of vessels after implantation of AITC with VEGF pellet in the rat cornea, and changes in the area of neovascularization on the seventh day of AITC implantation with VEGF pellet are shown. The values are shown as mean ± SEM of 3 independent experiments. The effect of AITC is statistically significant in comparison with controls (P < .001). Typical results from 3 independent experiments are shown. was further confirmed by inhibition of neovascularization in chick eggs. To evaluate the efficacy of AITC on corneal angiogenesis, we performed a rat cornea assay. Results in Figure 7B indicate that hydron pellets containing saline failed to stimulate an angiogenic response in rat corneas 5 to 7 days after implantation. A strong angiogenic response was seen with the pellet containing recombinant VEGF (1 µg/µL). This angiogenic response was completely blocked by the addition of AITC (10mM) to the pellet containing VEGF. Number of vessels ( Figure 7C ), length of vessels ( Figure 7D) , and area of blood vessels ( Figure 7E ) in the rat cornea demonstrated that AITC specifically and potently inhibited corneal angiogenesis induced by VEGF. effect of AITC. Acridine orange/ethidium bromide ( Figure 9A ) or Giemsa ( Figure 9B ) staining of EAT cells treated with AITC indicated nuclear condensation as compared with the untreated EAT cells. The cells treated with AITC showed typical apoptotic morphology, which included condensed nuclei, membrane blebbing, and formation of apoptotic bodies. In contrast, the control cells showed intact nuclear architecture.
AITC Induces Translocation of CAD
In apoptotic cells, cleavage of inhibitor of CAD (ICAD) by the caspase-3 protease activates CAD. Western blot analysis of nuclear extract of AITC-treated and untreated EAT cells showed the presence of CAD in AITC-treated EAT cells as compared with the untreated cells ( Figure 10A ). The CAD protein was identified in the nuclear extract of treated cells and increased with time as compared with the controls wherein CAD was not detected.
Bcl-2 and Bax Are Involved in AITC-Induced Apoptosis
Western blot analysis was performed to observe changes in the expression of Bcl-2 and Bax proteins during AITCinduced EAT cell apoptosis. As shown in Figure 10B , at different time intervals after treatment with AITC, a decreased expression of Bcl-2 was evident, whereas that of Bax protein began to increase. Therefore, our data suggest that the ratio of apoptotic antagonist (Bcl-2) and apoptotic agonist (Bax) is also related to AITC-induced apoptosis.
Effect of AITC on Cell Cycle Progression in EAT Cells
To elucidate the possible mechanism of AITC-mediated tumor inhibition, we investigated the effect of AITC on EAT cells. We found that treatment of EAT cells with AITC induced a significant proportion of cells to undergo apoptosis, as determined by the flow cytometric analysis. Cell cycle analysis by flow cytometry was used to quantitatively estimate the number of cells in each phase of the cell cycle. EAT cells were treated for 1, 2, 4, 8, and 16 hours with AITC and analyzed. The untreated cells (control) showed a typical distribution in G1, S, and G2 phases on flow cytometry. After treatment, the number of cells in the sub-G0 area increased by 20% at 2 hours and by more than 70% at 8 hours ( Figure 11 ). These results suggested that the fragmentation of DNA in EAT cells results in tumor killing.
Discussion
The role of natural products as a source of remedies has been recognized since ancient times. During the past decade, major advances have been made in the field of angiogenesis, including the elucidation of pathways of several angiogenic factors and the discovery of several natural and synthetic angiogenesis stimulators and inhibitors, leading to the translation of experimental drugs into clinical use. It is clear that plants have the potential to be a rich source of angiogenesis modulators, and it is noteworthy that cancer chemotherapeutic strategies commonly require multiple agents. 35 It has been demonstrated that the oil extracted from Curcuma aromatica shows antitumor activity on various cancer cells in vitro and in vivo. 36 A novel glycoprotein from Urginea indica bulbs has been shown to possess potent antitumor activity against growth of ascites tumor. 37 Recent studies have reported that the extracts of Tinospora cordifolia and Glycyrrhiza glabra have potent antiangiogenic and antitumor activity against mouse mammary carcinoma. 38, 39 Especially in regard to anticancer activity, it appears that several Brassica genus vegetables inhibit the growth of tumor cells. In the present study, we have focused on delineating the antiangiogenic and apoptotic effects of the essential oil of mustard seeds containing AITC on EAT cells. Most of the studies on Brassica genus vegetables involve apoptotic pathways of different cancer cells rather than antiangiogenic pathways. It is plausible that the antiangiogenic effects may play an important role in mediating the anticancer activity of AITCs. Hence, we investigated the dual effects of AITC on EAT cells.
The antiproliferative activity of AITC as evidenced by thymidine incorporation assay in EAT cells in vitro in a dose-dependent manner clearly indicates that the compound is most effective at a concentration of 10 µM. Concentrations above 10 µM proved to be cytotoxic, as shown by inhibition of proliferation of normal HEK293 cells. As cited in the literature, CAM assay and rat cornea assay are the standard angiogenesis assays used for the validation of angioinhibitory effect activity of different compounds. [31] [32] [33] Inhibition of neovascularization on CAM and rat cornea confirms the angioinhibitory effect of AITC. CAM and rat cornea assays are considered to be one of the best in vivo assays. Because VEGF is a mitogen for endothelial cells, it was used as a positive control in both the assays. Inhibition of VEGF-induced neovascularization by AITC supports our view that AITC may repress the expression of VEGF-like factors or inhibit the secretion of such factors, thereby inhibiting the formation of new blood vessels. The dietary compound curcumin is known for its antioxidant and anticarcinogenic properties. The literature shows that curcumin treatment significantly decreases VEGF gene expression in ascites tumor. 30 Decreased production of VEGF and consequently NOTE: Nuclear extracts were prepared from both control and AITC-treated cells; 50 µg of protein sample was resolved on 12% SDS-PAGE and transferred to a nitrocellulose membrane. CAD protein was detected using anti-CAD rabbit polyclonal antibody. Lane 1, controls; lanes 2 to 5, AITC-treated nuclear extract for different time intervals. Effect of AITC on Bax and Bcl-2 protein expression in EAT cells. Cytosolic extracts were prepared from both control and AITC-treated cells; 50 µg of protein sample was resolved on 12% SDS-PAGE and transferred to a nitrocellulose membrane. Bax and Bcl-2 protein expression were detected using rabbit polyclonal antibody against Bax and Bcl-2, respectively. Lane 1, controls; lanes 2 to 5, cytosolic extracts from cells treated for different time intervals. Density of the specific Bax and Bcl-2 protein band was analyzed with quantity one image software (Bio-Rad, Hercules, CA), and the results are expressed as percentage of internal control (β-actin) band density. Data are represented as mean ± SEM of 3 independent experiments. decreased peritoneal angiogenesis in AITC-treated mice further indicated the role of AITC in the regulation of VEGF gene expression. A decrease in the cell number of EAT cells treated with AITC in vitro strongly explained the antiproliferative effect of AITC. AITC inhibited ascites tumor growth in vivo and reduced EAT cell numbers without being cytotoxic to the cells as verified by trypan blue dye exclusion method. The morphological hallmarks of apoptosis such as nuclear condensation and internucleosomal fragmentation of DNA were clearly observed in AITC-treated EAT cells. One of the nucleases primarily responsible for genomic DNA fragmentation during apoptosis is called DNA fragmentation factor (DFF-40) or CAD. 40 In Western blot analysis, AITC was shown to activate a series of proteins involved in apoptosis. Caspases are cysteine proteases that play a critical role in the execution of apoptosis. 41, 42 Several chemotherapeutic and chemopreventive agents have been shown to cause apoptotic cell death through activation of caspases. 41, 43 Apoptosis signals activate a cascade of caspases, including caspase-8. The substrate for caspase-8 is BID protein, whose cleaved C-terminal fragment triggers cytochrome C release from mitochondria. The released cytochrome C binds to Apaf-1, which includes autoactivation of caspase-9, which in turn activates caspase-3. Caspase-3, a major executioner caspase on activation, can systemically dislodge the cells by cleaving key proteins, such as poly-ADP-ribose polymerase, 40, 41 lamins, and ICAD downstream of the cascade, resulting in programmed cell death. [43] [44] [45] On caspase activation by external stimuli, CAD dissociates from ICAD and translocates to the nucleus to disrupt the genetic material. 40 Treatment of EAT cells with AITC shows the activation of CAD, which is a downstream target for caspase-3 in EAT cells.
Members of the Bcl-2 family of proteins interact to regulate apoptosis. 46 The balance between protein levels of these members is crucial for the cellular decision of starting the apoptotic process. Proapoptotic members of this family include Bax protein and apoptotic inhibitors that include Bcl-2 protein. 47, 48 In our study, it was found that the reduced expression of Bcl-2 and increased expression of Bax protein-the activation of CAD through caspase-3 in EAT cells resulting in functional alteration of the mitochondria-may be potentially involved in the AITC-induced apoptotic responses. These results indicate the apoptotic signaling pathway of AITC in EAT cells.
Induction of apoptosis and/or cell proliferation inhibition is highly correlated with the activation of a variety of intracellular signaling pathways to arrest the cell cycle in the G1, S, or G2 phase. In malignant tumors, cell populations in the G1 phase appear less frequently than in normal tissue. The damages that cause G1 checkpoint arrest are believed to be an irreversible process, and the cell ultimately undergoes apoptosis. Our results indicate that AITC causes an increase in cells in the sub-G0 region in a time-dependent manner, with a decrease in cells in the G1, G2, and S-phase regions. Thus, it can be concluded that AITC has the ability to induce apoptosis in proliferating cells.
In conclusion, AITC extracted from mustard seeds contains both antiangiogenic and proapoptotic activities. AITC effectively inhibited angiogenesis in the CAM, rat cornea, and mouse peritoneum. It also exhibited potent proapoptotic activity by activating CAD and Bax protein and downregulating the Bcl-2 protein. Results of fluorescence activated cell sorter analysis also proved that AITC was capable of arresting the growth of EAT cells. Taken together, these findings clearly suggest that AITC may be a potential supplemental source for cancer treatment and warrants further investigation.
